Smith & Nephew generated $1.3 billion in revenue during its second quarter, up 48.2% from the previous year.

Dexcom generated $595.1 in sales and $62.9 million in profits during its second quarter, which ended June 30.

Exo, a startup that developed a handheld ultrasound device and a platform to support it, raised $200 million in its Series C funding round. Most of the new capital will toward commercializing the device.

Ultrasound and other imaging methods are being used to diagnose athletes' injuries at the Tokyo Olympics. For example, one New Zealand athlete underwent an ultrasound during a pre-Olympic soccer match.

The Jot Dx insertable cardiac monitor, which may help remotely identify cardiac arrhythmia and improve diagnosis accuracy, has been released by Abbott.

European regulators have given CE mark certification to MeMed for its MeMed COVID-19 Severity tool that could help determine the risk of severe outcomes in people.

The FDA has given breakthrough status designation to Biofourmis for its BiovitalsHF medical device software that is used to treat heart failure.

The FDA has given 510(k) clearance to NYU Langone Health for its Genome PACT genetic test for solid tumors.

European regulators have given CE-IVD mark certification to Cepheid for two PCR-based tests that detect HIV-1, its Xpert HIV-1 Qual XC and its Xpert HIV-1 Viral Load XC.

Health Canada has given its approval to Luxsonic for its SieVRt, a software that would allow radiologists to use a virtual reality headset to diagnose patients remotely.

Join us for a timely webinar focused on the FDA Breakthrough Devices Program and best practices for participation. Hosted by AdvaMed, this webinar will feature presentations from key FDA and CMS staff, followed by an engaging roundtable discussion and Q&A with FDA, CMS and industry. Webinar attendees will have the opportunity to submit questions upon registration or during the webinar. Registration for the webinar is free for AdvaMed members and government employees. Learn more.

The MedTech Conference, powered by AdvaMed, will host its trademark award-winning programming and networking opportunities in a new hybrid structure, combining the benefits of both in-person and virtual events, on September 27-30. Attendees can participate in The MedTech Conference in a fully virtual environment, and they can also take advantage of limited-capacity in-person gatherings in Washington, D.C., and in Minneapolis, Minnesota. For more information on The MedTech Conference 2021, visit the FAQs page, which will continue to be updated over the coming months.